Device Trial Radar · NCT01476917
The ATLAST Long-Term Study
Last checked: Nov 19, 2026Latest source record: Nov 7, 2012 (this record)Source: ClinicalTrials.govMethods & limitations
Status
Completed
Enrollment
39
Actual
Start
Nov 2011
Primary completion
Jun 2012
Study completion Oct 2012
Sponsor
- Lead sponsor
- ApniCure, Inc.Not on our public-company list
- Sponsor type
- Industry
- First posted
- Nov 22, 2011
Design
- Study type
- Interventional
- Phase
- Phase 2 / Phase 3
- Allocation
- Not applicable (single group)
- Model
- Single group
- Masking
- None
- Primary purpose
- Treatment
- Who can join
- All sexes, from 18 years, up to 80 years
- Healthy volunteers
- No
Summary
As written by the sponsor on the registry.
The Study is a multi-center, prospective, open label, single-arm, three-month, long-term study of the Attune Sleep Apnea System for the treatment of obstructive sleep apnea (OSA). The objective of the study is to monitor long-term use of the Attune Sleep Apnea System.
Conditions
- Obstructive Sleep Apnea (OSA)
Interventions
Attune Sleep Apnea SystemDevice
Observation of Attune Sleep Apnea System for use during sleep.
Primary outcomes
What the sponsor says the trial is designed to measure.
- Mean number of hours per night of device use over a 3-month periodTime frame: Each night's use
Locations
6 sites in 1 country. Site status is shown where the registry gives one.
REM Medical
Phoenix, Arizona
Penninsula Sleep Center (PSC)
Burlingame, California
SRI International
Menlo Park, California
3 more study sites with a free account
Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.